Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for …
Biotechnology
US, Los Altos [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Unicycive Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Unicycive Therapeutics, Inc. has no acquisition track records yet.